LAUSR

Use of CT and Chest Radiography for Lung Cancer Screening Before and After Publication of Screening Guidelines: Intended and Unintended Uptake

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA Internal Medicine"

DOI: 10.1001/jamainternmed.2016.9016

Abstract: Use of CT and Chest Radiography for Lung Cancer Screening Before and After Publication of Screening Guidelines: Intended and Unintended Uptake The National Lung Screening Trial (NLST) released its main findings in 2011,1 concluding that… read more here.

Keywords: intended unintended; cancer screening; lung cancer; cancer ... See more keywords

Red Flag on Electrocardiogram Findings in a Patient With Lung Cancer.

Sign Up to like & get
recommendations!
3 Published in 2023 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2023.0346

Abstract: This case report describes a patient in their early 70s with sudden onset squeezing precordial chest pain, back pain, and nausea, and a history of long-term lung cancer treatment. read more here.

Keywords: flag electrocardiogram; lung cancer; electrocardiogram findings; lung ... See more keywords

Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy for Bone Metastases

Sign Up to like & get
recommendations!
0 Published in 2018 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2018.3242

Abstract: Key Points Question What are the optimal factors to use for constructing a nomogram to assess the probability of survival in patients with bone metastases arising from lung cancer? Findings This prognostic study of 477… read more here.

Keywords: bone metastases; patients metastatic; survival patients; lung cancer ... See more keywords

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results

Sign Up to like & get
recommendations!
0 Published in 2019 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2019.0204

Abstract: Key Points Question In this study of data from the National Lung Screening Trial (NLST), can a lung cancer risk model’s prediction be improved by inclusion of lung cancer screening results? Findings In this secondary… read more here.

Keywords: cancer risk; model; lung cancer; lung ... See more keywords

Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines

Sign Up to like & get
recommendations!
2 Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.29741

Abstract: Key Points Question What consequences have the 2021 changes to the US Preventive Services Task Force screening guidelines for lung cancer had for the racial gap in lung cancer screening eligibility between Black and White… read more here.

Keywords: lung cancer; eligibility; lung; screening guidelines ... See more keywords

Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit?

Sign Up to like & get
recommendations!
1 Published in 2022 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2022.43171

Abstract: Lung cancer remains the leading cause of cancer death in the US, largely because most patients have advanced, incurable disease at the time of diagnosis. Lung cancer screening with low-dose computed tomography (LDCT) therefore has… read more here.

Keywords: lung cancer; lung; cancer screening; benefit ... See more keywords

Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.

Sign Up to like & get
recommendations!
2 Published in 2023 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2022.52885

Abstract: Importance Localization of subcentimeter ground glass opacities during minimally invasive thoracoscopic lung cancer resections is a significant challenge in thoracic oncology. Intraoperative molecular imaging has emerged as a potential solution, but the availability of suitable… read more here.

Keywords: lung cancer; intraoperative molecular; molecular imaging; sgm 101 ... See more keywords

Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta

Sign Up to like & get
recommendations!
2 Published in 2023 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2023.0787

Abstract: Key Points Question How does the cumulative incidence of lung cancer for persons aged 50 to 80 years in a lung nodule monitoring program (LNP) compare with that in a lung cancer screening (LDCT) cohort?… read more here.

Keywords: lung cancer; lnp cohort; lung; ldct cohort ... See more keywords

Potential of Prospective Particle Therapy Trials to Increase the Therapeutic Ratio for Locally Advanced Lung Cancer.

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA oncology"

DOI: 10.1001/jamaoncol.2017.2165

Abstract: Efforts to increase tumor control and minimize toxic effects to normal tissue have been long-sought goals in the treatment of patients with locally advanced solid tumors who receive multimodal therapeutic approaches. For patients with non–… read more here.

Keywords: particle therapy; particle; locally advanced; oncology ... See more keywords

Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE)

Sign Up to like & get
recommendations!
2 Published in 2022 at "JAMA Oncology"

DOI: 10.1001/jamaoncol.2021.7664

Abstract: Key Points Question Can modern radiation techniques reduce the risk of radiation-associated esophageal adverse effects in patients with advanced lung cancer? Findings In this phase 3 randomized clinical trial of esophageal-sparing intensity-modulated radiotherapy (ES-IMRT) or… read more here.

Keywords: lung cancer; radiation advanced; advanced central; lung ... See more keywords

Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial.

Sign Up to like & get
recommendations!
1 Published in 2022 at "JAMA oncology"

DOI: 10.1001/jamaoncol.2022.2719

Abstract: Importance The inability to obtain a pathological diagnosis in a certain proportion of patients with clinically diagnosed advanced lung cancer impedes precision treatment in clinical practice. Objective To evaluate the clinical outcome of first-line icotinib… read more here.

Keywords: lung cancer; trial; lung; diagnosed advanced ... See more keywords